The present invention pertains to 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds of formula (I), as well as the resulting pharmaceutical compositions, and their use in the treatment or prophylaxis of diseases alleviated by inhibition of type 5 phosphodiesterases. Furthermore, the present invention pertains to the methods of manufacturing these 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds.
本发明涉及式(I)的6-苄基-2,3,4,7-四氢
吲哚[2,3-c]
喹啉化合物,以及由此产生的药物组合物,以及它们在治疗或预防通过抑制5型
磷酸二酯酶缓解的疾病中的用途。此外,本发明涉及制造这些6-苄基-2,3,4,7-四氢
吲哚[2,3-c]
喹啉化合物的方法。